The Value of Early and Follow-Up Elevated Scores Based on Peripheral Complete Blood Cell Count for Predicting Adverse Outcomes in COVID-19 Patients
Authors:
- Andrei-Costin ChelariuACAndrei-Costin Chelariu
- Adorata Elena ComanACAdorata Elena Coman
- Catalina LionteCLCatalina Lionte
- Victoria GorciacVGVictoria Gorciac
- Victorita SorodocVictorita Sorodoc
- Raluca Ecaterina HaligaRHRaluca Ecaterina Haliga
- Ovidiu Rusalim PetrisOPOvidiu Rusalim Petris
- Cristina BologaCBCristina Bologa
- Gabriela PuhaGPGabriela Puha
- Alexandra StoicaASAlexandra Stoica
- Mihai ConstantinMCMihai Constantin
- Oana SirbuOSOana Sirbu
Open Access
- 9 December 2022
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (12) , 2037
Abstract
Background: The ongoing COVID-19 pandemic has put a constant strain on hospital resources, so there is a dire need for investigation methods that are widely available and that can predict mortality and the need for critical care. Hematological indices, which can be easily calculated from a complete blood count (CBC), are useful in determining a patient’s inflammatory response to infectious diseases. Aim: This was a prospective cohort study that aimed to assess the prognostic value of scores based on CBCs in hospitalized patients with mild or moderate COVID-19 and medical comorbidities regarding the need for intensive care unit (ICU) therapy and short-term mortality. Methods: We included 607 patients with confirmed COVID-19, followed up for the need for ICU admission (15.5%) and 30 day mortality post-discharge (21.7%). CBC-derived scores were tested upon emergency department (ED) admission and after a median of 8 days. Results: In a multivariate model, elevated followed-up neutrophil-to-lymphocyte ratio (NLR) predicted increased odds for ICU admission (OR: 1.14 [95%CI: 1.06–1.22], p < 0.001) and short-term mortality (OR: 1.30 [95%CI: 1.09–1.57], p = 0.005). Monocyte-to-lymphocyte ratio (MLR) predicted 2.5-fold increased odds for ICU admission and 2.2-fold increased odds for mortality. Conclusion: NLR and MLR followed up 8 days post-admission are predictive for adverse outcomes in mild or moderate COVID-19 patients.Keywords
This publication has 35 references indexed in Scilit:
- Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19Journal of Medical Virology, 2020
- Diagnostic and Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Early and Late Phase of SepsisIndian Journal of Critical Care Medicine, 2018
- Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?Mediators of Inflammation, 2018
- Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumabLung Cancer, 2017
- Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysisOncotarget, 2017
- Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysisBreast Cancer Research, 2017
- Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysisAnnals of Surgical Oncology, 2015
- Neutrophil to lymphocyte ratio and cardiovascular diseases: a reviewExpert Review of Cardiovascular Therapy, 2013
- A national early warning score for acutely ill patientsBMJ, 2012
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987